|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 6499 Topsails Lane |
Address2 | |
City | Springfield |
State | VA |
Zip Code | 22150 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 285277-12
|
||||||||
|
6. House ID# 369190000
|
TYPE OF REPORT | 8. Year | 2010 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Alfred W. Cors, Jr. |
Date | 04/18/2010 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AGR
16. Specific lobbying issues
Oppose Dairy Import Assessment Fee
Oppose S. 1542, H.R. 3674
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alfred W. |
Cors |
Jr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
S. 515 - Support Common Collision Repair/Access to Repair Parts Waiver and language to protect and encourage biotechnology research.
Support HR 3059 and S. 1368
Support Patent deadline extension in certain cases
Commented to The Intellectual Property Enforcement Coordinator regarding the critical importance of strong international intellectual property protection for the original research-based producers of pharmaceutical and biologic drugs, and medical devices.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alfred W. |
Cors |
Jr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 1548 - Pathway for Biosimilars Act
Oppose Physician-Owned Hospital restrictions in H.R. 3200, H.R. 3962, H.R. 3590, and all health care reform measures
H.R. 756/ S.660 - Support National Pain Care Policy Act of 2009
Oppose use of comparative effectiveness research to determine health care coverage or reimbursement decisions
Support Health IT funding and standards
Support Hagen/Enzi/Hatch Amendment to S. 325
Support HR 1894 and S. 769
Support Eshoo/Barton Amendment on biosimilars (to H.R. 3200) in House Energy and Commerce Committee
Support increased Osteoporosis screening funds in health care reform bills
Support request for House Oversight Committee hearings on prostate cancer, additional efforts to screen for and treat
Oppose the establishment of a "Super MedPAC" Commission empowered to cut Medicare payments and benefits
Oppose the Medicare cuts included in H.R. 3200, H.R. 3962, H.R. 3590, and all health care reform measures
Oppose Senate Amendment 2793
Support McCain Motion to Recommit H.R. 3590 with instructions to remove all Medicare cuts
Support Senate Amendment 2942
Support H.R. 3790
Support H.R. 2115
Support patient-centered comparative effectiveness research language passed by the Senate in H.R. 3590
Support 340B Federal Drug Discount Program purchasing provisions passed by the House and Senate in H.R. 3590
Oppose all efforts to shorten the 12-year exclusivity period provided (in both the House and Senate health care reform bills) for the original biologic drug as it pertains to a safe pathway for biosimilar "follow-on" drugs
Support "Specialty Tier" pricing relief in Medicare Part D Drug Plans and in CMS rulemaking regarding those plans.
Support increased funding to address the growing national burden of arthritis, including intervention and prevention plans.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), White House Office, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alfred W. |
Cors |
Jr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
S. 42 Support bill to reform Social Security Totalization process
H.R. 132 - Support ban on Social Security benefits for illegal aliens
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alfred W. |
Cors |
Jr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
S. 677 - Oppose means-tested Medicare Part D premiums
Oppose use of comparative effectiveness research to determine health care coverage or reimbursement decisions
Support Fibromyalgia patients access to medicines
Oppose Physician-Owned Hospital reimbursement ban
Support "six protected classes" in Medicare Part D
Support reduction or elimination of the "two-year wait" for Medicare for the disabled
Support Medicare Part D "off-label" drug rules similar to those relating to Medicare Part B
Oppose off-label drug mandates by insurance companies that replace approved medications
Oppose specialty tiers, therapeutic substitution, step therapy, dose restrictions and/or quantity limits that supplant first line treatments and physician orders for cost purposes
Oppose using Medicare cuts to pay for Health Care Reform in H.R. 3200, H.R. 3962, H.R. 3590, and all health care reform measures
Support "Specialty Tier" pricing relief in Medicare Part D Drug Plans and in CMS rulemaking regarding those plans.
Oppose the establishment of a "Super MedPAC" Commission empowered to cut Medicare payments and benefits
Support 340B Federal Drug Discount Program purchasing provisions passed by the House and Senate in H.R. 3590.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alfred W. |
Cors |
Jr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code RET
16. Specific lobbying issues
H.R. 1067 - Notch Fairness Act
H.R. 236 - Social Security Protection Act
H.R. 322- repeal of Social Security Earnings Test
H.R. 1519/H.R. 883/ H.R. 1058 -repeal of income taxes on Social Security benefits
H.R. 541 - index the Social Security benefit income tax threshold limits for tax purposes to inflation
Support a fair and accurate cost-of-living adjustment annually for Social Security beneficiaries
Support H.R. 2365, H.R. 3557, and H.R.3572
Support legislation mandating the establishment of a senior-specific Consumer Price Idex for Seniors (CPI-S)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alfred W. |
Cors |
Jr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
H.R. 99 - the Fair and Simple Tax Act of 2009
H.R. 198 - Health Care Tax deduction Act of 2009
H.R. 205 - the Death Tax Repeal Act
H.R. 85 - Marriage Tax Penalty Permanent Elimination Act of 2009
H.R. 199 - Simple Savings Tax Relief Act of 2009
H.R. 379 - State and Local Sales Tax Deduction Expansion Act of 2009
H.R. 498 - Capital Gains and Estate Tax Relief Act of 2009
H.R. 544 - Flexible Health Savings Act of 2009
H.R. 897 - Long-Term Care and Retirement Security Act of 2009
H.R. 1560 - Permanent Internet Tax Freedom Act of 2009
H.R. 1960 - Permanent Death Tax Repeal Act of 2009
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alfred W. |
Cors |
Jr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AUT
16. Specific lobbying issues
Motor Vehicle Owners Right to Repair Act-Support HR 2057
Support HR 3059 and S. 1368
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alfred W. |
Cors |
Jr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SMB
16. Specific lobbying issues
Support Small Business Innovation Research Grant Program Reauthorization language (H.R. 2965) to allow small businesses to fully participate when they have venture capital firms as significant or majority investors, and oppose the original language regarding this issue in S. 1233.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alfred W. |
Cors |
Jr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TEC
16. Specific lobbying issues
Support the expansion and use of broadband technology, and support efforts to provide broadband access to all Americans.
Support H.R. 760, S. 1266, and H.R. 2428
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alfred W. |
Cors |
Jr. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |